AVR

Profile

Full Name

Anteris Technologies Global Corp.

Ticker Symbol

AVR

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

Australia

IPO

December 13, 2024

Indexes

Not included

Website

http://anteristech.com

Employees

136

Key Details

Price

$3.07(+18.99%)

Market cap

$110.34M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$2.73M(-14.56% YoY)

Annual EPS

-$1.28(-50.58% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$3.07
AVR price is $3.07

30-Day Relative Volume

1.52
AVR 30-day relative volume is 1.52

Price Performance

Price Most recent change

+18.99%
AVR price was up +18.99% on Apr 15, 2025

Price YTD change

-44.98%
AVR price is down -44.98% since January 1st

Price 1-year change

-
AVR price 1-year change is unknown

Price 3-year change

-
AVR price 3-year change is unknown

Price Range

Price All-time high

$8.79
AVR price is currently -65.07% below its historical high of $8.79

Price 3-year low

$2.34
AVR price is currently +31.20% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$110.34M
AVR market capitalization is $110.34 million

Market cap 3-year change

-
AVR market capitalization 3-year change is unknown

Market cap All-time high

$306.93M
AVR market capitalization is currently -64.05% below its historical high of $306.93 million

Market cap sector rank

49.59%
AVR market capitalization is higher than 49.59% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-
AVR shares outstanding 1-year change is unknown

Shares Outstanding 3-Year Change

-
AVR shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.23
AVR beta is 1.23

200-day SMA

$5.86
AVR price is currently -47.60% below its 200-day simple moving average

50-day SMA

$5.92
AVR price is currently -48.11% below its 50-day simple moving average

RSI

34.49
AVR 14-day relative strength index is 34.49

Volume

1.52
AVR 30-day relative volume is 1.52

ATR

$0.57
AVR average true range is $0.57

10-day Historical Volatility

197.25%
AVR 10-day historical volatility is 197.25%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$2.73M
AVR annual revenue is $2.73 million

Revenue Analysts estimate

$4.91M
AVR annual revenue is currently -44.32% lower than the consensus analysts' forecast

Revenue 1-year change

-14.56%
AVR annual revenue is down -14.56% year-on-year

Revenue Sector rank

17.65%
AVR annual revenue is higher than 17.65% of companies in Healthcare sector

EPS

EPS

-$1.28
AVR annual earnings per share is -$1.28

EPS Analysts estimate

-$2.92
AVR annual earnings per share is currently -56.15% lower than the consensus analysts' forecast

EPS 1-year change

-50.58%
AVR annual earnings per share is down -50.58% year-on-year

EPS Sector rank

49.79%
AVR annual earnings per share is higher than 49.79% of companies in Healthcare sector

Profit

Gross profit

$876.80K
AVR annual gross profit is $876.80 thousand

Gross margin

32.06%
AVR annual gross profit margin is 32.06%

Operating profit

-$46.79M
AVR annual operating income is -$46.79 million

Operating margin

-1710.83%
AVR annual operating profit margin is -1710.83%

Net income

-$46.02M
AVR annual net profit is -$46.02 million

Net margin

-1682.81%
AVR annual net profit margin is -1682.81%

Expenses

Total expenses

$49.52M
AVR annual total expenses is $49.52 million

Operating expenses

$47.66M
AVR annual total operating expenses is $47.66 million

Cost of goods sold

$1.86M
AVR annual cost of goods sold is $1.86 million

Selling, general & administrative expenses

$17.05M
AVR annual SGA is $17.05 million

Depreciation and amortization

$1.16M
AVR annual depreciation & amortization is $1.16 million

Interest expense

$67.10K
AVR annual interest expense is $67.10 thousand

Income tax

$0.00
AVR annual income tax is $0.00

EBIT & EBITDA

EBIT

-$46.70M
AVR annual earnings before interest & taxes is -$46.70 million

EBITDA

-$45.54M
AVR annual EBITDA is -$45.54 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$30.53M
AVR annual total assets is $30.53 million

Non current assets

$6.31M
AVR annual long term assets is $6.31 million

Current assets

$24.22M
AVR annual total current assets is $24.22 million

Cash and cash equivalents

$21.03M
AVR annual cash & cash equivalents is $21.03 million

Accounts receivable

$407.60K
AVR annual accounts receivable is $407.60 thousand

Inventory

$442.30K
AVR annual inventory is $442.30 thousand

Liabilities

Total liabilities

$11.63M
AVR annual total liabilities is $11.63 million

Long term liabilities

$2.17M
AVR annual total long term liabilities is $2.17 million

Current liabilities

$9.46M
AVR annual total current liabilities is $9.46 million

Accounts payable

$3.14M
AVR annual accounts payable is $3.14 million

Debt

Total debt

$1.60M
AVR annual total debt is $1.60 million

Total debt 1-year change

+67.47%
AVR annual total debt is up +67.47% year-on-year

Long term debt

$926.80K
AVR annual long term debt is $926.80 thousand

Short term debt

$668.90K
AVR annual short term debt is $668.90 thousand

Equity & Capital

Shareholders equity

$19.30M
AVR annual stockholders equity is $19.30 million

Book value

$19.30M
AVR annual book value is $19.30 million

Retained earnings

-$200.10M
AVR annual retained earnings is -$200.10 million

Working capital

$14.77M
AVR annual working capital is $14.77 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$34.63M
AVR annual cash flow from operations is -$34.63 million

Cash from operations 1-year change

-17.73%
AVR annual cash flow from operations is down -17.73% year-on-year

Cash from investing

-$2.58M
AVR annual cash flow from investing activities is -$2.58 million

Cash from investing 1-year change

-160.09%
AVR annual cash flow from investing activities is down -160.09% year-on-year

Cash from financing

$49.34M
AVR annual cash flow from financing activities is $49.34 million

Cash from financing 1-year change

+112.02%
AVR annual cash flow from financing activities is up +112.02% year-on-year

CAPEX

CAPEX

$2.39M
AVR annual capital expenditures is $2.39 million

CAPEX 1-year change

+43.75%
AVR annual capital expenditures is up +43.75% year-on-year

Free Cash Flow

Free cash flow

-$37.03M
AVR annual free cash flow is -$37.03 million

Free cash flow 1-year change

-19.12%
AVR annual free cash flow is down -19.12% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

32.06%
AVR annual gross profit margin is 32.06%

Operating margin

-1710.83%
AVR annual operating profit margin is -1710.83%

Net margin

-1682.81%
AVR annual net profit margin is -1682.81%

ROA & ROE

ROA

-197.89%
AVR annual return on assets is -197.89%

ROE

-329.54%
AVR annual return on equity is -329.54%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
AVR price to earnings ratio value is unknown

PE ratio Sector rank

-
AVR price to earnings ratio is unknown

PB Ratio

PB ratio

35.03
AVR price to book ratio is 35.03

PB ratio Sector rank

98.02%
AVR price to book ratio is higher than 98.02% of companies in Healthcare sector

PS Ratio

PS ratio

40.70
AVR price to sales ratio is 40.70

PS ratio Sector rank

91.15%
AVR price to sales ratio is higher than 91.15% of companies in Healthcare sector

Enterprise value

Enterprise value

$102.91M
AVR enterprise value is $102.91 million

Enterprise value Sector rank

50.62%
AVR enterprise value is higher than 50.62% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.47
AVR EV/EBITDA is -1.47

EV/EBITDA Sector rank

37.42%
AVR EV/EBITDA is higher than 37.42% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.56
AVR annual current ratio is 2.56

Quick ratio

2.51
AVR annual quick ratio is 2.51

Leverage

Debt to equity

0.00
AVR annual debt to equity ratio is 0.00

Interest coverage ratio

-695.92
AVR annual interest coverage ratio is -695.92

Risk & Stability

Piotroski F-Score

-
AVR piotroski f-score value is unknown

Altman Z-Score

-7.86
AVR altman z-score is -7.86

Analyst ratings

Recent major analysts updates

Jan 8, 25 Lake Street
Buy
Jan 7, 25 TD Cowen
Buy
Jan 7, 25 Cantor Fitzgerald
Overweight
Jan 7, 25 Barclays
Overweight

Institutional Ownership

Similar stocks

KRMD logo
KORU Medical Systems (KRMD)
ENTA logo
Enanta Pharmaceuticals (ENTA)
AMWL logo
American Well (AMWL)
CSBR logo
Champions Oncology (CSBR)
TNXP logo
Tonix Pharmaceuticals Holding (TNXP)
EDIT logo
Editas Medicine (EDIT)
BTMD logo
biote (BTMD)
ZTEK logo
Zentek (ZTEK)
OBIO logo
Orchestra BioMed Holdings (OBIO)
  • What is the ticker symbol for Anteris Technologies Global?
  • Does Anteris Technologies Global pay dividends?
  • What sector is Anteris Technologies Global in?
  • What industry is Anteris Technologies Global in?
  • What country is Anteris Technologies Global based in?
  • When did Anteris Technologies Global go public?
  • Is Anteris Technologies Global in the S&P 500?
  • Is Anteris Technologies Global in the NASDAQ 100?
  • Is Anteris Technologies Global in the Dow Jones?
  • When does Anteris Technologies Global report earnings?
  • Should I buy Anteris Technologies Global stock now?

What is the ticker symbol for Anteris Technologies Global?

The ticker symbol for Anteris Technologies Global is NASDAQ:AVR

Does Anteris Technologies Global pay dividends?

No, Anteris Technologies Global does not pay dividends

What sector is Anteris Technologies Global in?

Anteris Technologies Global is in the Healthcare sector

What industry is Anteris Technologies Global in?

Anteris Technologies Global is in the Medical Instruments & Supplies industry

What country is Anteris Technologies Global based in?

Anteris Technologies Global is headquartered in Australia

When did Anteris Technologies Global go public?

Anteris Technologies Global's initial public offering (IPO) was on December 13, 2024

Is Anteris Technologies Global in the S&P 500?

No, Anteris Technologies Global is not included in the S&P 500 index

Is Anteris Technologies Global in the NASDAQ 100?

No, Anteris Technologies Global is not included in the NASDAQ 100 index

Is Anteris Technologies Global in the Dow Jones?

No, Anteris Technologies Global is not included in the Dow Jones index

When does Anteris Technologies Global report earnings?

The date for Anteris Technologies Global's next earnings report has not been announced yet

Should I buy Anteris Technologies Global stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page